Inogen | INGN - Ebitda


Inogen reported $-9.42M in EBITDA for its fiscal quarter ending in September of 2023.





Ebitda Change Date
Abbott USD 3.27B 178M Dec/2025
Accuray USD -685K 900K Sep/2024
AngioDynamics USD 5.94M 3.78M Sep/2025
Artivion USD 22.72M 1.84M Dec/2025
AtriCure USD 17.07M 2.79M Mar/2026
Baxter International USD -447M 873M Dec/2025
Becton, Dickinson and Co. USD 1.71B 433M Dec/2025
Boston Scientific USD 1.16B 213M Dec/2025
Chart Industries USD 124.1M 51.8M Mar/2026
Cooper Companies USD 323.4M 13.2M Dec/2025
Dexcom USD 364.5M 57.7M Mar/2026
Edwards Lifesciences USD 70.1M 394.2M Dec/2025
Globus Medical USD 280.46M 27.86M Dec/2025
Insulet USD 181.7M 12.3M Mar/2026
Masimo USD 85.5M 6.4M Mar/2026
Medtronic USD 2.93B 482M Dec/2025
Orthofix International USD 27.88M 2.77M Dec/2025
Philips EUR 567M 233M Mar/2026
ResMed USD 547.48M 27.46M Dec/2025
Steris USD 394.7M 5M Dec/2025
Stryker USD 1.57B 618M Mar/2026
Tandem Diabetes Care USD 2.73M 30.17M Mar/2026
Teleflex USD 247.07M 575.88M Dec/2025
X T L Biopharmaceuticals USD -479K 19K Dec/2024
Zimmer Biomet Holdings USD 759M 120.8M Dec/2025